APO RESEARCH · REPORT
Stem Cell Therapy
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Product & engineering
Understand the product.
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Selected research
Industry Research
Stem Cell Therapy Industry Research Report 2026
Market perspective
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.
The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.
Read the full market overview
Report Scope
This report quantifies the global Stem Cell Therapy market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Stem Cell Therapy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Stem Cell Therapy Market by Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Molmed
Takeda (TiGenix)
Stem Cell Therapy Segment by Type
Autologous
Allogeneic
Stem Cell Therapy Segment by Application
Musculoskeletal Disorder
Wounds & Injuries
Cornea
Cardiovascular Diseases
Others
Stem Cell Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Autologous
- Allogeneic
Applications
- Musculoskeletal Disorder
- Wounds & Injuries
- Cornea
- Cardiovascular Diseases
- Others
Companies covered
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- JCR Pharmaceutical
- Pharmicell
- Medi-post
- Anterogen
- Molmed
- Takeda (TiGenix)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Stem Cell Therapy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Autologous
- 2.2.3 Allogeneic
- 2.3 Stem Cell Therapy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Musculoskeletal Disorder
- 2.3.3 Wounds & Injuries
- 2.3.4 Cornea
- 2.3.5 Cardiovascular Diseases
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Stem Cell Therapy Breakdown Data by Type
- 3.1 Global Stem Cell Therapy Historic Market Size by Type (2021-2026)
- 3.2 Global Stem Cell Therapy Forecasted Market Size by Type (2027-2032)
4 Stem Cell Therapy Breakdown Data by Application
- 4.1 Global Stem Cell Therapy Historic Market Size by Application (2021-2026)
- 4.2 Global Stem Cell Therapy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Stem Cell Therapy Market Perspective (2021-2032)
- 5.2 Global Stem Cell Therapy Growth Trends by Region
- 5.2.1 Global Stem Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Stem Cell Therapy Historic Market Size by Region (2021-2026)
- 5.2.3 Stem Cell Therapy Forecasted Market Size by Region (2027-2032)
- 5.3 Stem Cell Therapy Market Dynamics
- 5.3.1 Stem Cell Therapy Industry Trends
- 5.3.2 Stem Cell Therapy Market Drivers
- 5.3.3 Stem Cell Therapy Market Challenges
- 5.3.4 Stem Cell Therapy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Stem Cell Therapy Players by Revenue
- 6.1.1 Global Top Stem Cell Therapy Players by Revenue (2021-2026)
- 6.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2021-2026)
- 6.2 Global Stem Cell Therapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Stem Cell Therapy Head Office and Area Served
- 6.4 Global Stem Cell Therapy Players, Product Type & Application
- 6.5 Global Stem Cell Therapy Manufacturers Established Date
- 6.6 Global Stem Cell Therapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Stem Cell Therapy Market Size (2021-2032)
- 7.2 North America Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Stem Cell Therapy Market Size by Country (2021-2026)
- 7.4 North America Stem Cell Therapy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Stem Cell Therapy Market Size (2021-2032)
- 8.2 Europe Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Stem Cell Therapy Market Size by Country (2021-2026)
- 8.4 Europe Stem Cell Therapy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Stem Cell Therapy Market Size (2021-2032)
- 9.2 Asia-Pacific Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Stem Cell Therapy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Stem Cell Therapy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Stem Cell Therapy Market Size (2021-2032)
- 10.2 South America Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Stem Cell Therapy Market Size by Country (2021-2026)
- 10.4 South America Stem Cell Therapy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Stem Cell Therapy Market Size (2021-2032)
- 11.2 Middle East & Africa Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Stem Cell Therapy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Stem Cell Therapy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Osiris Therapeutics
- 12.1.1 Osiris Therapeutics Company Information
- 12.1.2 Osiris Therapeutics Business Overview
- 12.1.3 Osiris Therapeutics Revenue in Stem Cell Therapy Business (2021-2026)
- 12.1.4 Osiris Therapeutics Stem Cell Therapy Product Portfolio
- 12.1.5 Osiris Therapeutics Recent Developments
- 12.2 NuVasive
- 12.2.1 NuVasive Company Information
- 12.2.2 NuVasive Business Overview
- 12.2.3 NuVasive Revenue in Stem Cell Therapy Business (2021-2026)
- 12.2.4 NuVasive Stem Cell Therapy Product Portfolio
- 12.2.5 NuVasive Recent Developments
- 12.3 Chiesi Pharmaceuticals
- 12.3.1 Chiesi Pharmaceuticals Company Information
- 12.3.2 Chiesi Pharmaceuticals Business Overview
- 12.3.3 Chiesi Pharmaceuticals Revenue in Stem Cell Therapy Business (2021-2026)
- 12.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio
- 12.3.5 Chiesi Pharmaceuticals Recent Developments
- 12.4 JCR Pharmaceutical
- 12.4.1 JCR Pharmaceutical Company Information
- 12.4.2 JCR Pharmaceutical Business Overview
- 12.4.3 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2021-2026)
- 12.4.4 JCR Pharmaceutical Stem Cell Therapy Product Portfolio
- 12.4.5 JCR Pharmaceutical Recent Developments
- 12.5 Pharmicell
- 12.5.1 Pharmicell Company Information
- 12.5.2 Pharmicell Business Overview
- 12.5.3 Pharmicell Revenue in Stem Cell Therapy Business (2021-2026)
- 12.5.4 Pharmicell Stem Cell Therapy Product Portfolio
- 12.5.5 Pharmicell Recent Developments
- 12.6 Medi-post
- 12.6.1 Medi-post Company Information
- 12.6.2 Medi-post Business Overview
- 12.6.3 Medi-post Revenue in Stem Cell Therapy Business (2021-2026)
- 12.6.4 Medi-post Stem Cell Therapy Product Portfolio
- 12.6.5 Medi-post Recent Developments
- 12.7 Anterogen
- 12.7.1 Anterogen Company Information
- 12.7.2 Anterogen Business Overview
- 12.7.3 Anterogen Revenue in Stem Cell Therapy Business (2021-2026)
- 12.7.4 Anterogen Stem Cell Therapy Product Portfolio
- 12.7.5 Anterogen Recent Developments
- 12.8 Molmed
- 12.8.1 Molmed Company Information
- 12.8.2 Molmed Business Overview
- 12.8.3 Molmed Revenue in Stem Cell Therapy Business (2021-2026)
- 12.8.4 Molmed Stem Cell Therapy Product Portfolio
- 12.8.5 Molmed Recent Developments
- 12.9 Takeda (TiGenix)
- 12.9.1 Takeda (TiGenix) Company Information
- 12.9.2 Takeda (TiGenix) Business Overview
- 12.9.3 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2021-2026)
- 12.9.4 Takeda (TiGenix) Stem Cell Therapy Product Portfolio
- 12.9.5 Takeda (TiGenix) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst